Benitec Biopharma Inc. 10-K/A filing
Filed 2026-03-20 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001193125-26-117604
- Form type
- 10-K/A
- CIK
- 0001808898
- Primary document
- https://www.sec.gov/Archives/edgar/data/1808898/000119312526117604/d226768d10ka.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Benitec Biopharma Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-41.8M | - | - |
| Net Income | $-37.9M | - | - |
| Eps Basic | -1.05 | - | - |
| Eps Diluted | -1.05 | - | - |
| Cash And Equivalents | $97.7M | - | - |
| Total Assets | $99.6M | - | - |
| Total Liabilities | $2.3M | - | - |
| Shareholders Equity | $97.3M | - | - |
| Operating Cash Flow | $-23.6M | - | - |
| Capital Expenditures | $18,000 | - | - |